You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Goat polyclonal Secondary Antibody to Human IgM - mu chain (DyLight® 650) (ab96990)

Overview

  • Product nameGoat polyclonal Secondary Antibody to Human IgM - mu chain (DyLight® 650)See all IgM secondary antibodies ...
  • Target speciesHuman
  • SpecificityBy immunoelectrophoresis and ELISA this antibody reacts specifically with Human IgM. Cross reactivity with other immunoglobulins and light chains is less than 0.1%.
  • Tested applicationsIHC-P, ICC/IF, Flow Cyt more details

Properties

Applications

Our Abpromise guarantee covers the use of ab96990 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
IHC-P IHC-P: 1/50 - 1/500. DyLight®650 replaces DyLight®649. The DyLight®650 excitation is 652nm and the emission is 672nm. DyLight®650 hence provides the same far-red fluorescence and photostability as the DyLight®649 dye. Please refer to the vial in order to check whether the product you received is DyLight®649 or DyLight®650. This information however will have no impact on your experiments. For more information please refer to www.abcam.com/DyLight650.
ICC/IF ICC/IF: 1/50 - 1/500.
Flow Cyt Flow Cyt: 1/50 - 1/200.

Goat polyclonal Secondary Antibody to Human IgM - mu chain (DyLight® 650) images

  • Emission spectra of DyLight® fluorochromes available in our catalog.
    Line colors represent the approximate visible colors of the wavelength maxima.

References for Goat polyclonal Secondary Antibody to Human IgM - mu chain (DyLight® 650) (ab96990)

ab96990 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab96990.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"